Jamal Wadi Al-Ramahi*, Mahmoud Al-QaimariÃÂ and Haifa Petro RN
Background: Most studies focused on the cost and the environmental effects of the reprocessed single-use devices (SUDs), rarely on their clinical effects. We aim to evaluate the reprocessed SUDs use safety.
Methods: A prospective charts review between January 2017-August 2018 was conducted in a tertiary care hospital in Amman, Jordan. The hospital has a policy to re-sterilize the SUDs up to three times not based on an evidence but was based on staff observations/opinions of the cardiac catheterization (CC) supervisors, central sterilization and supply department, and the infection control department staff. Reprocessed SUDs were colormarked for ranks. The CC laboratory supervisor who collected data was aware of the ongoing study and the infection prevention and control coordinators. Our primary measure was CC-related adverse events; fever, sepsis, bleeding, and up to a month all-cause mortality.
Results: There were 818 Patients, males 582 (71.1%), age (mean 61.85 years, median 59 (IQR 49-69). For all reprocessed SUDs ranks, the admission diagnoses were coronary artery disease, valvular heart disease, acute coronary event and heart failure. Commonest comorbidities were hypertension and diabetes mellitus.
Conclusion: Four evaluated outcomes revealed no significant differences for patients who were in various ranks; no fever, sepsis (p>0.2), bleeding (p>0.2), and all-cause mortality (p>0.2).
Published Date: 2019-02-11; Received Date: 2019-01-20